Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

Worth their weight in gray matter? A narrative review of cost‐effectiveness analyses of monoclonal antibodies for Alzheimer's disease

Saved in:
Bibliographic Details
Published in:Alzheimer's & Dementia: Translational Research & Clinical Interventions
Format: Online Article RSS Article
Published: 2026
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1867301677823950850
collection WordPress RSS
FRELIP Feed Integration
container_title Alzheimer's & Dementia: Translational Research & Clinical Interventions
description
discipline_display Gerontology and Geriatrics
discipline_facet Gerontology and Geriatrics
format Online Article
RSS Article
genre Journal Article
id rss_article:69989
institution FRELIP
journal_source_facet Alzheimer's & Dementia: Translational Research & Clinical Interventions
publishDate 2026
publishDateSort 2026
record_format rss_article
spellingShingle Worth their weight in gray matter? A narrative review of cost‐effectiveness analyses of monoclonal antibodies for Alzheimer's disease
Gerontology and Geriatrics
General
Gerontology and Geriatrics
sub_discipline_display General
sub_discipline_facet General
subject_display Gerontology and Geriatrics
General
Gerontology and Geriatrics
Gerontology and Geriatrics
General
Gerontology and Geriatrics
subject_facet Gerontology and Geriatrics
General
Gerontology and Geriatrics
title Worth their weight in gray matter? A narrative review of cost‐effectiveness analyses of monoclonal antibodies for Alzheimer's disease
title_auth Worth their weight in gray matter? A narrative review of cost‐effectiveness analyses of monoclonal antibodies for Alzheimer's disease
title_full Worth their weight in gray matter? A narrative review of cost‐effectiveness analyses of monoclonal antibodies for Alzheimer's disease
title_fullStr Worth their weight in gray matter? A narrative review of cost‐effectiveness analyses of monoclonal antibodies for Alzheimer's disease
title_full_unstemmed Worth their weight in gray matter? A narrative review of cost‐effectiveness analyses of monoclonal antibodies for Alzheimer's disease
title_short Worth their weight in gray matter? A narrative review of cost‐effectiveness analyses of monoclonal antibodies for Alzheimer's disease
title_sort worth their weight in gray matter? a narrative review of cost‐effectiveness analyses of monoclonal antibodies for alzheimer's disease
topic Gerontology and Geriatrics
General
Gerontology and Geriatrics
url https://alz-journals.onlinelibrary.wiley.com/doi/10.1002/trc2.70267?af=R